#EASD2022 Wrap-up and highlight with Luigi Gnudi and Leszek Czupryniak @EASDiabetes

Uploaded September 2022 | Updated September 2026, 3 days ago

Catch the highlights from Day 2 of EASD 2024 as Luigi Gnudi and Leszek Czupryniak share their top takeaways from the Congress. From Michael Naok's Claude Bernard Lecture on incretin hormones to Professor Horowitz's session on gastroparesis, we explore the latest in diabetes treatment and research. Plus, learn about innovations in diabetes care, microRNAs, and spinal stimulation for neuropathy.

Stay updated on the latest breakthroughs and research shaping the future of diabetes care. Don’t miss out—subscribe for more insights from EASD!

#easd2022 #diabetes #t1d #t2d

#EASD2022 Wrap-up and highlight with Luigi Gnudi and Leszek Czupryniak

EASD 2024 - Can Pre-diabetes Remission Reduce Global Diabetes Incidence?

EASD2025: Dementia in Diabetes: Reasons for Hope or Concern

EASD 2025: Update of the Consensus Report on the Management of Type 1 Diabetes in Adults

#EASD2022 Interview with the EFSD Novo Nordisk Foundation Future Leaders

EASD 2024 - Global Perspectives on Diabetes

Meet the EASD Early Career Academy - Introducing Agata Grzelka-Wozniak

1st EASD Early Career Academy Webinar: Science communication masterclass

EASD2025: Tailored Nutrition and Low-Calorie Diet Remission Updates

Best of EASD 2025 by the EASD Early Career Academy - featuring Dr. Vaios Koutroukas

EASD 2024: What Can We Learn About Diabetes from Indigenous Populations & Genetic Discoveries?

EASD 2023 - Katherine Tuttle and Hiddo Heerspink about Chronic Kidney Disease in type 1 diabetes